FIELD: gynecology. SUBSTANCE: invention consists in additionally examining levels of testosterone, its metabolites, androgens, estrogens, 17-hydroxycorticosteroids, and catecholamines in blood and urine. When levels of testosterone in blood and its metabolites in urine are elevated and androgens are in excess of active estrogens in blood, 2-4 mg peritol daily in evening time is administered perorally within 5 days. With data reflecting reduced testosterone metabolism and androsterone production, one teaspoonful of laminaria trice a day within 1-2 months is administered. With high level of 7-hydroxycorticosteroids in urine, administered are: 1/2 glass of immortelle flower tincture trice a day or 2-3 spoonfuls of corn stigmas 4 times a day, 3-5 mg carsil in the day and before night, and 1 teaspoonful trice a day. With high dopamine level, 2.5 mg diazepam in the morning and evening daily within 1-1.5 months is used. With reduced excretion of dopa and dopamine, 34 mg nacom in the morning time is administered within 1- 1.5 months. At last, when catecholamine excretion rhythm is disturbed and night releases of noradrenaline and dopamine become prevailing, 29 mg dipheninum in the morning in 15 min after nacom has been taken and 0.5 mg phenazepam before night within 1-1.5 months are prescribed. EFFECT: accelerated appearance of remission and prolonged its duration.
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DIAGNOSING VULVAL CARCINOMA | 1990 |
|
RU2023265C1 |
METHOD OF DETERMINING LESION OF SYMPATHOMIMETIC SYSTEM UNDER DUCHENNE MYODYSTROPHY | 0 |
|
SU1255928A1 |
METHOD FOR PREDICTING VULVA CANCER TREATMENT RESULTS | 1998 |
|
RU2153175C1 |
METHOD OF PROGNOSTICATING VULVAL CARCINOMA RELAPSES | 1990 |
|
RU2023266C1 |
METHOD FOR DIAGNOSING AND TREATING NEUROMUSCULAR DISEASES OF DOPAMINE ETIOLOGY | 1992 |
|
RU2061962C1 |
METHOD OF TREATING PARALYSES AND EPILEPSIES IN ANIMALS | 1992 |
|
RU2028801C1 |
METHOD OF TREATING PRECANCEROUS AND EARLY STAGES OF CANCEROUS DISEASES OF STOMACH | 2011 |
|
RU2467758C1 |
PHARMACEUTICAL COMPOSITION FOR RECOVERY FUNCTION OF SYMPATHETIC-ADRENAL SYSTEM, METHOD OF EVALUATION OF INDIVIDUAL EFFECTIVENESS OF THIS COMPOSITION FOR PATIENT THERAPY | 1999 |
|
RU2157196C1 |
METHOD OF INDIVIDUAL RECOVERY OF FUNCTIONAL ACTIVITY OF ADRENAL CORTEX IN PATIENTS WITH SOMATIC DISEASES WITH LONG HISTORY OF GLUCOCORTICOSTEROID THERAPY | 2010 |
|
RU2439563C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF ADRENAL GROWTHS | 2015 |
|
RU2583918C1 |
Authors
Dates
1997-07-20—Published
1991-01-09—Filed